HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yuh-Ling Lin Selected Research

Triaziquone

7/2010A study on inhibition mechanism of breast cancer cells by bis-type triaziquone.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yuh-Ling Lin Research Topics

Disease

2Breast Neoplasms (Breast Cancer)
07/2010 - 01/2005
1Pancreatic Neoplasms (Pancreatic Cancer)
06/2011
1Mouth Neoplasms (Oral Cancer)
01/2006
1Neoplasms (Cancer)
06/2004
1Myocardial Infarction
08/2002

Drug/Important Bio-Agent (IBA)

3Pharmaceutical PreparationsIBA
07/2010 - 01/2005
2TamoxifenFDA LinkGeneric
07/2010 - 01/2005
2NaphthoquinonesIBA
01/2006 - 01/2005
2Proteins (Proteins, Gene)FDA Link
01/2005 - 06/2004
1PlatinumIBA
06/2011
1TriaziquoneIBA
07/2010
1quinone (benzoquinone)IBA
07/2010
1Apoptosis Regulatory ProteinsIBA
01/2006
1Bisbenzimidazole (Hoechst 33258)IBA
01/2005
1Paclitaxel (Taxol)FDA LinkGeneric
01/2005
1bis-aziridinylnaphthoquinoneIBA
06/2004
1AntibodiesIBA
08/2002
1ThromboxanesIBA
08/2002
1oxidized low density lipoproteinIBA
08/2002
12,5-dichloro-4-bromophenol (B 2)IBA
08/2002
1LDL Lipoproteins (beta Lipoproteins)IBA
08/2002
1AutoantibodiesIBA
08/2002
1Epoprostenol (Prostacyclin)FDA LinkGeneric
08/2002